{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panel Levofloxacin (0.12 to 16 mcg/ml)",
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062276",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020556"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "August 23, 2006",
    "Summary Letter Received Date": "August 7, 2006",
    "Submission Date": "July 25, 2006",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Levofloxacin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Microdilution",
        "Broth dilution susceptibility test"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel Levofloxacin antimicrobial susceptibility testing using microdilution and instrument read capability",
    "Indications for Use Summary": "Determines antimicrobial susceptibility to Levofloxacin for aerobic streptococci including Streptococcus pneumoniae, with instrument and visual read options",
    "fda_folder": "Microbiology"
}